Patent · US Active

Formulations of a compound modulating kinases

US10961240B2 · kind B2 · utility

3Cited by

72References

30Claims

0Family size

Assignees

Plexxikon Inc. · US
DAIICHI SANKYO COMPANY, LIMITED · JP

Inventors

Prabha N. Ibrahim · Mountain View, US
Hamid Rezaei · Berkeley, US
Gary Conard Visor · Rue de l'Église, US
Tomoari Kamo · Tokyo, JP
Hiroshi Yamakose · Nagoya, JP

Key dates

Filing date	Jul 12, 2019
Grant date	Mar 30, 2021
Priority date	—
Expiry date	Jul 12, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are compositions comprising Compound I having the following structure: or a pharmaceutically acceptable salt thereof, and a solubilizing agent; methods of making the same; and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.